Navigation

Researchers at UCD

researcher

Patrick Mallon

College Lecturer/Consultant (Infectious Diseases)

School Of Medicine & Medical Science
Mater Hospital
Eccles Street
Dublin 7

Tel:
Email: paddy.mallon@ucd.ie

Professional

         

Conference Contributions

Cotter A, Brown A, Sheehan G, Lambert JS, Mallon P.; (2008) Patients with HIV and Hepatitis C co-infection experience less Atazanavir-induced hyperbilirubinaemia. [Poster Presentation (Refereed)], 14th Annual BHIVA Conference, Belfast, Northern Ireland , 23-APR-08 - 25-APR-08.
   

Education

Year 1995 Institution: Queen's University of Belfast, UK
Qualification: MB, BCh, BAO Subject:
Year 2005 Institution:
Qualification: FRC Path Subject:
Year 1995 Institution: Queen's University of Belfast, UK
Qualification: BCL Subject:
Year 1995 Institution: Queen's University of Belfast, UK
Qualification: MB Subject:
Year 1993 Institution: Queen's University of Belfast, UK
Qualification: BSc Subject:
         

Publications

 

Book Chapters

McGinty T, Mallon PWG. (2012) 'Pharmacology of Antiretroviral Drugs' In: Somesh Gupta, Bhushan Kumar (eds). Sexually Transmitted Infections. New Delhi, India: Elsevier. , pp.805-825 [Details]
 

Peer Reviewed Journals

Tinago, W; O'Halloran, J; O'Halloran, R; Macken, A; Lambert, J; Sheehan, G; Mallon, P; (2013) 'Characterization of associations and development of atazanavir resistance after unplanned treatment interruptions'. HIV Medicine, . [DOI] [Details]
Sadlier, CM; Brown, A; Lambert, J; Sheehan, G; Mallon, PW (2013) 'Seroprevalence of Schistosomiasis and Strongyloides infection in HIV-infected patients from endemic areas attending a European infectious diseases clinic'. Seroprevalence of Schistosomiasis and Strongyloides infection in HIV-infected patients from endemic areas attending a European infectious diseases clinic, 10 (1). Available Online [Details]
Martin A, Moore C, Mallon PW, Hoy J, Emery S, Belloso W, Phanuphak P, Ferret S, Cooper DA, Boyd MA; Second Line study team. (2013) 'Bone mineral density in HIV participants randomized to raltegravir and lopinavir/ritonavir compared with standard second line therapy'. AIDS, 27 (18):2403-2411. [DOI] [Details]
Feeney, ER,van Vonderen, MGA,Wit, F,Danner, SA,van Agtmael, MA,Villarroya, F,Domingo, P,Capeau, J,Reiss, P,Mallon, PWG (2012) 'Zidovudine/lamivudine but not nevirapine in combination with lopinavir/ritonavir decreases subcutaneous adipose tissue mitochondrial DNA'. AIDS, 26 :2165-2174. [DOI] [Details]
Cotter, AG,Vrouenraets, SME,Brady, JJ,Wit, FW,Fux, CA,Furrer, H,Brinkman, K,Sabin, CA,Reiss, P,Mallon, PWG (2013) 'Impact of Switching From Zidovudine to Tenofovir Disoproxil Fumarate on Bone Mineral Density and Markers of Bone Metabolism in Virologically Suppressed HIV-1 Infected Patients; A Substudy of the PREPARE Study'. Journal Of Clinical Endocrinology & Metabolism, 98 :1659-1666. [DOI] [Details]
Feeney, ER,McAuley, N,O'Halloran, JA,Rock, C,Low, J,Satchell, CS,Lambert, JS,Sheehan, GJ,Mallon, PWG (2013) 'The Expression of Cholesterol Metabolism Genes in Monocytes From HIV-Infected Subjects Suggests Intracellular Cholesterol Accumulation'. The Journal of infectious diseases, 207 :628-637. [DOI] [Details]
Cotter, AG,Satchell, CS,O'Halloran, JA,Feeney, ER,Sabin, CA,Mallon, PWG; (2011) 'High-density lipoprotein levels and 10-year cardiovascular risk in HIV-1-infected patients'. AIDS, 25 :867-869. [DOI] [Details]
Feeney, ER,Mallon, PWG; (2011) 'Insulin resistance in treated HIV infection'. Practice, 25 :443-458. [DOI] [Details]
Satchell, CS,O'Halloran, JA,Cotter, AG,Peace, AJ,O'Connor, EF,Tedesco, AF,Feeney, ER,Lambert, JS,Sheehan, GJ,Kenny, D,Mallon, PWG; (2011) 'Increased Platelet Reactivity in HIV-1-Infected Patients Receiving Abacavir-Containing Antiretroviral Therapy'. Journal of Infectious Diseases, 204 :1202-1210. [DOI] [Details]
Feeney ER, Chazallon C, O¿Brien N, Meiffredy V, Goodall RL, Aboulker JP, Cooper DA, Yeni P, Mallon PWG on behalf of the INITIO Trial International Co-ordinating Committee. (2011) 'Risk factors associated with lactic acidosis / symptomatic hyperlactatemia for HIV-infected patients on antiretroviral therapy enrolled in a randomised clinical trial: a sub-study of the INITIO trial'. HIV Medicine, 12 (10):602-609. [DOI] [Details]
Cotter AG, Mallon PW (2011) 'HIV infection and bone disease: implications for an aging population'. Sexual Health, 8 (4):493-501. [Details]
Fox D, O'Connor R, Mallon P, McMahon G. (2011) 'Simultaneous determination of efavirenz, rifampicin and its metabolite desacetyl rifampicin levels in human plasma'. Journal of Pharmaceutical and Biomedical Analysis, 56 (4):785-791. [Details]
Satchell, CS,Cotter, AG,O'Connor, EF,Peace, AJ,Tedesco, AF,Clare, A,Lambert, JS,Sheehan, GJ,Kenny, D,Mallon, PWG; (2010) 'Platelet function and HIV: a case-control study'. AIDS, 24 :649-657. [DOI] [Details]
Mallon PW; (2010) 'HIV and bone mineral density'. Current Opinion in Infectious Diseases, 23 (1):1-8. [DOI] [Details]
Kearney H, Mallon P, Kavanagh E, Lawler L, Kelly P, O¿Rourke K. (2010) 'Amnestic syndrome due to meningovascular neurosyphilis'. Journal of Neurology, 257 (4):669-671. [Details]
Feeney ER, Mallon PWG. (2010) 'Impact of Mitochondrial Toxicity of HIV-1 Antiretroviral Drugs on Lipodystrophy and Metabolic Dysregulation'. Current Pharmaceutical Design, 16 (30):3339-3351. [Details]
Doran PP, Cotter EJ, Mallon PW, ; (2009) 'Is PPARgamma a Prospective Player in HIV-1-Associated Bone Disease?'. PPAR research, 2009 (NA). [DOI] [Details]
Yilmaz, A,Izadkhashti, A,Price, RW,Mallon, PW,De Meulder, M,Timmerman, P,Gisslen, M; (2009) 'Darunavir Concentrations in Cerebrospinal Fluid and Blood in HIV-1-Infected Individuals'. AIDS, 25 :457-461. [DOI] [Details]
Read TR, Carey D, Mallon P, Mijch A, Goodall R, Hudson F, Wand H, Emery S. (2009) 'Efavirenz plasma concentrations did not predict cessation of therapy due to neuropsychiatric symptoms in a large randomized trial'. AIDS, 23 (16):2222-2223. [Details]
Gallagher, D. P., Kieran, J., Sheehan, G., Lambert, J., Mahon, N., Mallon, P. W. G. (2008) 'Ritonavir-boosted atazanavir, methadone, and ventricular tachycardia: 2 case reports'. Clinical Infectious Diseases, 47 (3):36-38. [Details]
Carr A, Mallon PW, Sedwell R, Rogers G, Nolan D, Unemori P, Hoy J, Samaras K, Kelleher A, Emery S, Cooper DA, ; (2008) 'Effect of rosiglitazone on peroxisome proliferator-activated receptor gamma gene expression in human adipose tissue is limited by antiretroviral drug-induced mitochondrial dysfunction'. The Journal of infectious diseases, 12 (NA):1794-1803. [DOI] [Details]

Other Journals

Mallon PW, Powderly WG; (2009) 'Management of late presentation of HIV: what the data tell us' HIV Therapy 3 :423-426. [Details]

Conference Publications

Mallon, PWG,Sedwell, R,Rogers, G,Nolan, D,Unemori, P,Hoy, J,Samaras, K,Kelleher, A,Emery, S,Cooper, DA,Carr, A (2008) JOURNAL OF INFECTIOUS DISEASES Effect of Rosiglitazone on Peroxisome Proliferator-Activated Receptor gamma Gene Expression in Human Adipose Tissue Is Limited by Antiretroviral Drug-Induced Mitochondrial Dysfunction , pp.1794-1803 [DOI] [Details]
                                                                                         

Research

Research Interests

Research Projects

Sponsor : Gilead Sciences
Title : 3M-BRiHT Project - Mater-Manchester-Modena-Bronx Rapid HIV Testing Project
Start Date / End Date : 01-FEB-13 / 30-APR-14
Sponsor : Gilead Sciences
Title : SWIFT Study: Switching from Lamivudine/Abacavir (3TC/ABC) to Emtricitabine/Tenofovir DF (FTC/TDF) Based Regimen ¿ Platelet and Inflammation Sub-study
Start Date / End Date : 28-JAN-13 / 31-JUL-14
Sponsor : Bristol Myers Squibb Pharmaceuticals
Title : Mater HIV/ID Cohort Project - BMS
Start Date / End Date : 21-DEC-12 / 31-DEC-14
Sponsor : Gilead Sciences
Title : The Mater Bronx Rapid HIV Testing Project (M-BRiHT Project)
Start Date / End Date : 02-JAN-12 / 28-DEC-14
Sponsor : Janssen-Cilag Ltd.
Title : Mater HIV-ID Cohort Project - Janssen
Start Date / End Date : 01-NOV-11 / 31-DEC-13
Sponsor : Merck Sharp & Dohme (Ireland)
Title : Mater HIV-ID Cohort Project - MSD
Start Date / End Date : 19-SEP-11 / 18-SEP-14
Sponsor : GlaxoSmithKline (Ireland) Ltd.
Title : Understanding the pathology of bone disease in HIV-infected patients
Start Date / End Date : 01-DEC-10 / 01-MAY-14
Sponsor : Health Research Board (HRB)
Title : Exploring Low Bone Mineral Density in HIV
Start Date / End Date : 01-OCT-10 / 01-OCT-13
Sponsor : Science Foundation Ireland (SFI)
Title : Exploring antiretroviral-induced adipose tissue toxicity through translational research
Start Date / End Date : 01-AUG-09 / 31-JUL-13
 

Current Postgraduate Students

Gerard O' Connor, Doctor of Philosophy (PhD)   -   Thesis Supervisor
Aoife Cotter, Doctor of Philosophy (PhD)   -   Thesis Supervisor
Jane O'Halloran, Doctor of Philosophy (PhD)   -   Thesis Supervisor
Willard Tinago, Doctor of Philosophy (PhD)   -   Thesis Supervisor
Robert Maughan, Doctor of Philosophy (PhD)   -   Thesis Supervisor